Association between blood group antigens and rheumatic valve involvement and severity in endemic areas
dc.authorscopusid | 35098471100 | |
dc.authorscopusid | 36161828100 | |
dc.authorscopusid | 26532378600 | |
dc.authorscopusid | 56256970400 | |
dc.authorscopusid | 24723991900 | |
dc.contributor.author | Ercan, Süleyman | |
dc.contributor.author | Altunbaş, Gökhan | |
dc.contributor.author | Akkoyun, Dursun Çayan | |
dc.contributor.author | Davutoglu, Vedat | |
dc.contributor.author | Deniz, Hayati | |
dc.date.accessioned | 2022-05-11T14:40:06Z | |
dc.date.available | 2022-05-11T14:40:06Z | |
dc.date.issued | 2013 | |
dc.department | Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalı | |
dc.description.abstract | Background: Rheumatic valve disease is an important public health problem in developing countries. We sought to evaluate the possible role of blood antigens as a risk factor for severe rheumatic valve disease. Methods: Two hundred and fifty-four patients with severe rheumatic mitral and/or aortic valve disease with the surgical indication were enrolled to the study. Control group was composed of age and gender matched 2668 healthy volunteers. Results: There were 216 patients with aortic valve involvement and 249 patients with mitral valve involvement. One hundred and seventy-five patients had mitral stenosis, 96 patients had severe mitral regurgitation and 61 patients had severe aortic regurgitation. The distribution of blood groups among patients was as follows: Group A-42.9%, Group B=19.2%, Croup AB =8.6%, and Croup O=29.1%. The distribution of blood groups in the control group was Group A=40.8%, Group B =16.4%, Croup AB=7.6%, and Croup O=35.1%. There was no significant difference between blood groups of patients and controls (p=0.141). Conclusion: Blood group does not seem to be a risk factor for rheumatic valve involvement or severity of the disease. (C) 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z.o.o. All rights reserved. | |
dc.identifier.doi | 10.1016/j.crvasa.2013.06.006 | |
dc.identifier.endpage | E426 | |
dc.identifier.issn | 0010-8650 | |
dc.identifier.issn | 1803-7712 | |
dc.identifier.issue | 5 | en_US |
dc.identifier.scopus | 2-s2.0-84888308235 | |
dc.identifier.scopusquality | Q4 | |
dc.identifier.startpage | E424 | |
dc.identifier.uri | https://doi.org/10.1016/j.crvasa.2013.06.006 | |
dc.identifier.uri | https://hdl.handle.net/20.500.11776/8868 | |
dc.identifier.volume | 55 | |
dc.identifier.wos | WOS:000409973000004 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.institutionauthor | Akkoyun, Dursun Çayan | |
dc.language.iso | en | |
dc.publisher | Elsevier Science Bv | |
dc.relation.ispartof | Cor Et Vasa | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Rheumatic valve disease | |
dc.subject | Blood group antigen | |
dc.title | Association between blood group antigens and rheumatic valve involvement and severity in endemic areas | |
dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- 8868.pdf
- Boyut:
- 156.64 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text